CloudMD Announces $10M Bought Deal

This evening CloudMD Software & Services Inc. (CSE: DOC) announced a $10M bought deal with a syndicate of underwriters co-led by Canaccord and Beacon. The underwriters agreed to purchase 14.3M units at a price of C$0.70 per unit with a full warrant priced at $1.00.

The stock has been on a role for the last month reaching a 52 week high of 95c.

The company also states they intend to use the proceeds of the offering for potential M&A activities to support their strategic growth plans and general corporate purposes.

The units will be offered by way of a short form prospectus and expected to close on June 2nd. The company granted the underwriters an option to purchase up to an additional 2.1M units at a price of C$0.70 per unit, exercisable at any time, for a period of 30 days after and including the closing date, which would result in additional proceeds of approximately C$1.5 million.

For full details, read the official company press release here.

The stock was halted all day and last traded at 77c.


FULL DISCLOSURE: CloudMD Software & Services is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover CloudMD Software & Services on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Soma Gold: Q3 Earnings Impacted By Labour Strike

Thesis Gold: The Multi-Billion Dollar Lawyers-Ranch PFS

Why Canada Has So Few Projects That Can Be Built Before 2030 | Dan Wilton – First Mining

Recommended

Steadright To Begin Selling Stockpile Material From Historic Goundafa Mine

Japan Gold Concludes Geophysical Survey At Hakuryu Project For Drill Targeting

Related News

Food Shortages May Become Reality Amid Coronavirus Pandemic

The global coronavirus pandemic has wreaked havoc across economies, closing down businesses, putting millions out...

Friday, April 24, 2020, 07:50:33 AM

Revive Therapeutics Sees FDA Recommend Phase 3 For COVID-19 Related Study Of Bucillamine

Revive Therapeutics (CSE: RVV) announced major news this morning related to its ongoing study of...

Thursday, April 23, 2020, 09:06:28 AM

April New Vehicle Sales Lowest Since 1990’s

Edmunds, which serves as an online resource for automotive information, recently published data on new...

Sunday, May 3, 2020, 10:04:00 AM

CloudMD Closes On $60 Million Acquisition Of VisionPros

CloudMD Software & Services (TSXV: DOC) this morning announced the closing of the acquisition of...

Thursday, June 24, 2021, 08:14:28 AM

Economic Sentiment Among Canadians Declines as COVID-19 Cases Continue to Soar

As an alarming second coronavirus wave overcomes many parts of Canada, the outlook on the...

Monday, October 26, 2020, 02:19:17 PM